Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5

1234511 Novel triazole compounds represented by Formula (1): (where A, A, A, A, A, A, B, R, W, X, Y and Z are as defined herein) in which the triazole is substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) anoth...

Full description

Saved in:
Bibliographic Details
Main Authors Cosford, Nicholas D. P, Roppe, Jeffrey R, Tehrani, Lida R, Wang, Bowei
Format Patent
LanguageEnglish
Published 11.09.2007
Online AccessGet full text

Cover

Abstract 1234511 Novel triazole compounds represented by Formula (1): (where A, A, A, A, A, A, B, R, W, X, Y and Z are as defined herein) in which the triazole is substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity and other diseases
AbstractList 1234511 Novel triazole compounds represented by Formula (1): (where A, A, A, A, A, A, B, R, W, X, Y and Z are as defined herein) in which the triazole is substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity and other diseases
Author Wang, Bowei
Roppe, Jeffrey R
Cosford, Nicholas D. P
Tehrani, Lida R
Author_xml – sequence: 1
  givenname: Nicholas D. P
  surname: Cosford
  fullname: Cosford, Nicholas D. P
– sequence: 2
  givenname: Jeffrey R
  surname: Roppe
  fullname: Roppe, Jeffrey R
– sequence: 3
  givenname: Lida R
  surname: Tehrani
  fullname: Tehrani, Lida R
– sequence: 4
  givenname: Bowei
  surname: Wang
  fullname: Wang, Bowei
BookMark eNqNyjsOwjAMANAMMPC7gy8QiYJa2PmIgZEdua1bRUriKHYGOD1F4gBMb3lLM4scaWHuZ2cxvzxIaUWdFqUeNDt8sycI3BePylmABwik2LJmTq6D0RfFgEqQqaM0HVuvzXxAL7T5uTJwvTxON1skTTOqPMeMX7aHXXOs6mr_R_kA4JY5KQ
ContentType Patent
CorporateAuthor Merck & Co., Inc
CorporateAuthor_xml – name: Merck & Co., Inc
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 07268151
GroupedDBID EFH
ID FETCH-uspatents_grants_072681513
IEDL.DBID EFH
IngestDate Sun Mar 05 22:33:07 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_072681513
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7268151
ParticipantIDs uspatents_grants_07268151
PatentNumber 7268151
PublicationCentury 2000
PublicationDate 20070911
PublicationDateYYYYMMDD 2007-09-11
PublicationDate_xml – month: 09
  year: 2007
  text: 20070911
  day: 11
PublicationDecade 2000
PublicationYear 2007
References Dornow et al, CA 53:17220, 1959.
(WO 03/051315) 20030600
Revesz. et al., SAR of 2,6-Diamino-3,5-difluoropyridinyl Substituted Heterocycles as Novel p38 MAP Kinase Inhibitors, Bioorganic & Medicinal Chemistry Letters, 12 (2002) 2109-2112.
References_xml – year: 20030600
  ident: WO 03/051315
Score 2.6875598
Snippet 1234511 Novel triazole compounds represented by Formula (1): (where A, A, A, A, A, A, B, R, W, X, Y and Z are as defined herein) in which the triazole is...
SourceID uspatents
SourceType Open Access Repository
Title Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7268151
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsQwcFgXQT0pKq4vcvAa7TNNz7pLEZU9KOxtaZvpstA2pc2y6Nc7aWXxotcEZoZM5pXMA-BOZqFA4Sjui1zxQGWSyziNeBRS7CC8OPP6WQSvbyL5CJ4X4WIEya4WpiIx4g3R0t1vusboPrmS1PvAeD40f7Y9AmvbfWBblzpVc1U8RJ6Qrq2l3pOOTe2bzpIjOCAQ5LLVpvtlNGbHsD_vV09ghPUpvDytedp-lqwjrMMHvWJ2aMaXLpFVWtlBWrrtmC5YhYaYY1rdrHO2osuRkmOJjLQTErEtD8-AzabvjwnfoV6uWpvSsnR-SPTPYUyhPV4A81KMMJNkUik4LEi8kNyFwM0xKDz0o3ACkz_BXP6zdwWHwxtkzF33Gsam3eANGU-T3fYn8w0FNHtx
link.rule.ids 230,309,783,805,888,64375
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzJoG4nECAWI8c-AaWLs-z2xVgTH1ANJuVdu406S2qdpMCL4ep0UTF7gmkuPE8St2bIA7L7UddMaCT5xMcEukHvf8xOWuTb6DY_qp2fUieF044bv1vLSXAwi3f2FKYiNeEy7t_aatleySK0m894TnffFnXSOw0tUHPqpCJiIS-YNrOp6h_1Lv6FCUTu6bBeEh7BMQMtoq1f5SG8ER7Ebd6DEMsDqB-XTNk-azYC2t24foBdNtM75kgayUQrfSkk3LZM5KVEQe1ch6nbEVXY-ETEtkJJ-Q0G24fQosmL09hny7dLxqdFJLPP5BcnIGQ3Lu8RyYmaCLqUdKldzDnBgMyWCwjAyt3ETaxwhGf4K5-GfuFvaiaRDPnxYvl3DQP0j63DCuYKiaDV6TJlXpTXdI3ztgfm0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Di-aryl+substituted+triazole+modulators+of+metabotropic+glutamate+receptor-5&rft.inventor=Cosford%2C+Nicholas+D.+P&rft.inventor=Roppe%2C+Jeffrey+R&rft.inventor=Tehrani%2C+Lida+R&rft.inventor=Wang%2C+Bowei&rft.number=7268151&rft.date=2007-09-11&rft.externalDBID=n%2Fa&rft.externalDocID=07268151